ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Tisotumab Biosimilar - Anti-Tissue Factor Antibody (Biotin) (A332070)

Recombinant human monoclonal antibody to Tissue Factor (Biotin) for ELISA.

Alternative Formats and ConjugatesAlternative Formats

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Name
Tisotumab Biosimilar - Anti-Tissue Factor Antibody (Biotin)
Description
Recombinant human monoclonal antibody to Tissue Factor (Biotin).
Applications
ELISA
Dilutions
ELISA: 1:5,000-1:10,000
Reactivity
Human
Host
Human
Clonality
Monoclonal
Isotype
IgG1
Conjugate

Biotin

Purification
Affinity chromatography.
Concentration
Reconstitution dependent.
Product Form
Lyophilized
Reconstitution
Reconstitute with distilled sterile water.
Formulation
Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
General Notes
Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.
Synonyms
CD142, Coagulation factor III, F3, TF, Thromboplastin
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Tisotumab Biosimilar - Anti-Tissue Factor Antibody (Biotin) (A332070)? Please let us know so that we can list the citation on this page.

Alternative products to Tisotumab Biosimilar - Anti-Tissue Factor Antibody (Biotin) (A332070)

Proteins predicted to interact with Tissue Factor

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.6% Relevancy Score
99.4% Relevancy Score
98.2% Relevancy Score
98% Relevancy Score
95.8% Relevancy Score
94.2% Relevancy Score